Flagship Harbor Advisors, LLC Hoth Therapeutics, Inc. Transaction History

Flagship Harbor Advisors, LLC

  • $1.74 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 08, 2021
SELL
$1.58 - $2.37 $6 - $9
-4 Closed
0 $0
Q2 2020

Jul 31, 2020
BUY
$2.53 - $4.08 $10 - $16
4 New
4 $0

Others Institutions Holding HOTH

# of Institutions
2
Shares Held
6K
Call Options Held
0
Put Options Held
0
View Full List

About Hoth Therapeutics, Inc.

HOTH Quotes by TradingView
  • Ticker HOTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,288,470
  • Market Cap $1.11M
  • Description
  • Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor ...
More about HOTH
Track This Portfolio

Track Flagship Harbor Advisors, LLC Portfolio

Follow Flagship Harbor Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email